Speech-based Assessment of Relapse Risk in People With Psychosis

Recruiting Observational Study
Psychotic Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Observational
Participants needed
360 (estimated)
Sponsor
Philipp Homan · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This observational, multinational study assesses the feasibility of speech and self-report data collection across six languages for Artificial Intelligence (AI)-driven relapse risk estimation in psychosis. Over 12 months, patients at risk of relapse and healthy controls will provide weekly speech recordings and self-report data for automated analysis. Risk scores will be stored but not shared with…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Healthy participants Inclusion Criteria: * Between 18 and 65 years old. * Subjects must be able to provide informed consent (IC). * Participants must have provided signed informed consent prior to enrollment. * Participants should not take prescription drugs regularly. * Native or equivalent fluenc…
Contacts

Philipp Homan, Prof. Dr. med. univ. PhD

+41 58 384 33 65

philipp.homan@bli.uzh.ch

CONTACT